Работы, цитирующие эту работу

Работ: 2

Работа: Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

1. Acute cerebrovascular events and inflammatory markers associated with COVID-19: An observational study

   Ibrahim A. Abdelazim, Merey Bakytzhanovna Jumagaliyeva, Dinmukhamed Nurniyazovich Ayaganov +3

   СтатьяLong-Term Effects of COVID-19Journal of Medicine and Life2023Цитирований: 0

   ABIABI:AkademIndex/openalex/2023.article.002473

2. Relationship between severe acute respiratory syndrome coronavirus 2 and diabetes mellitus (review)

   Gulnora Artykbaeva, Saatov Ts

   СтатьяAdvanced Glycation End Products researchDiabetes Mellitus2023Цитирований: 0

   ABIABI:AkademIndex/openalex/2023.article.002990